ArticleSeminars in arthritis and rheumatism2024

Reasons for multiple biologic and targeted synthetic DMARD switching and characteristics of treatment refractory rheumatoid arthritis.

Gregory C McDermott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.